Top 10 most significant diagnoses. by Lucas Vega (19500790)

N-acetilcysteine prevents the <i>A</i>. <i>simplex</i> CE-induced TEER decrease. by Noelia Carballeda-Sangiao (2889611)

Demographic and clinical characteristics of patients with newly diagnosed multiple myeloma and monoclonal gammopathy of undetermined significance. by Akiko Yamada (111970)

“…<p>Demographic and clinical characteristics of patients with newly diagnosed multiple myeloma and monoclonal gammopathy of undetermined significance.…”

The patients with PMR had a significant inflammatory gene expression profile, abundant inflammatory genes that may activate JAK signaling. by Xinlei Ma (1423633)

Subjects:

JNJ26993135 + BML-111 decreases permeability and enhances ZO-1 and claudin-1 induced by PAF but does not change TEER. by Kameljit K. Kalsi (16496511)

Data Sheet 1_Significance of multi-task deep learning neural networks for diagnosing clinically significant prostate cancer in plain abdominal CT.docx by Yujun Geng (21232145)

“…Objective<p>Early detection and timely surgical intervention are crucial in reducing mortality rates associated with clinically significant prostate cancer (csPCa). Currently, clinical diagnostics primarily depend on magnetic resonance imaging (MRI) and nuclear medicine, with the potential diagnostic value of abdominal computed tomography (CT) remaining underexplored. …”

Transepithelial electrical resistance (TEER) (N = 6). by Shirko Marcel Shokr (19173337)

“…<p><b>(A)</b> During the cultivation of SMC and ALI we observed significantly differences on day 18 (SMC: 9.61 kΩ*cm²; ALI: 7.73 kΩ*cm²; p<0.05) and day 25 (SMC: 8.19 kΩ*cm²; ALI: 6.44 kΩ*cm²; p<0.05) ALI cultures showed significantly decreased values compared to SMC. …”

Demographic and clinical characteristics of patients diagnosed with COVID-19. by Rebeka Caribé Badin (14599893)

Supplementary Data 5 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Figure 1 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 6 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 4 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 8 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Table_1_Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients.docx by Jinan Guo (8049647)

“…</p><p>Conclusions: The 24-Gene Classifier urine test is an accurate and non-invasive liquid biopsy method for identifying clinically significant prostate cancer in newly diagnosed cancer patients. …”

Supplementary Data 3 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 7 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 2 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 1 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 9 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Summary of clinical signs, CT findings and final diagnoses, per region. by Charles Tran (20496212)